Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6517
    -0.0019 (-0.29%)
     
  • OIL

    83.12
    +1.77 (+2.18%)
     
  • GOLD

    2,239.70
    +27.00 (+1.22%)
     
  • Bitcoin AUD

    108,100.88
    +2,516.19 (+2.38%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6039
    +0.0008 (+0.14%)
     
  • AUD/NZD

    1.0906
    +0.0026 (+0.24%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,257.94
    -22.90 (-0.13%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,788.45
    +28.37 (+0.07%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     

Earnings Estimates Moving Higher for Monroe Capital (MRCC): Time to Buy?

Monroe Capital (MRCC) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.

The upward trend in estimate revisions for this business development company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

Consensus earnings estimates for the next quarter and full year have moved considerably higher for Monroe Capital, as there has been strong agreement among the covering analysts in raising estimates.

ADVERTISEMENT

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate Revisions

The earnings estimate of $0.28 per share for the current quarter represents a change of +12% from the number reported a year ago.

Over the last 30 days, two estimates have moved higher for Monroe Capital compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 6.25%.

Current-Year Estimate Revisions

For the full year, the earnings estimate of $1.15 per share represents a change of +12.75% from the year-ago number.

There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, four estimates have moved up for Monroe Capital versus no negative revisions. This has pushed the consensus estimate 9.76% higher.

Favorable Zacks Rank

Thanks to promising estimate revisions, Monroe Capital currently carries a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

Investors have been betting on Monroe Capital because of its solid estimate revisions, as evident from the stock's 6.5% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Monroe Capital Corporation (MRCC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research